Mesa RA - Search Results

1

Proposed criteria for the diagnosis of post-polycythemia vera and post-essential thrombocythemia myelofibrosis: a consensus statement from the International Working Group for Myelofibrosis Research and Treatment.

Barosi G, Mesa RA, Thiele J, Cervantes F, Campbell PJ, Verstovsek S, Dupriez B, Levine RL, Passamonti F, Gotlib J, Reilly JT, Vannucchi AM, Hanson CA, Solberg LA, Orazi A, Tefferi A; International Working Group for Myelofibrosis Research and Treatment (IWG-MRT). Barosi G, et al. Among authors: mesa ra. Leukemia. 2008 Feb;22(2):437-8. doi: 10.1038/sj.leu.2404914. Epub 2007 Aug 30. Leukemia. 2008. PMID: 17728787 No abstract available.

2

Anagrelide as a new platelet-lowering agent in essential thrombocythemia: mechanism of actin, efficacy, toxicity, current indications.

Tefferi A, Silverstein MN, Petitt RM, Mesa RA, Solberg LA Jr. Tefferi A, et al. Among authors: mesa ra. Semin Thromb Hemost. 1997;23(4):379-83. doi: 10.1055/s-2007-996112. Semin Thromb Hemost. 1997. PMID: 9263355 Review.

3

Population-based incidence and survival figures in essential thrombocythemia and agnogenic myeloid metaplasia: an Olmsted County Study, 1976-1995.

Mesa RA, Silverstein MN, Jacobsen SJ, Wollan PC, Tefferi A. Mesa RA, et al. Am J Hematol. 1999 May;61(1):10-5. doi: 10.1002/(sici)1096-8652(199905)61:1<10::aid-ajh3>3.0.co;2-i. Am J Hematol. 1999. PMID: 10331505 Free article.

4

Bone marrow effects of anagrelide therapy in patients with myelofibrosis with myeloid metaplasia.

Yoon SY, Li CY, Mesa RA, Tefferi A. Yoon SY, et al. Among authors: mesa ra. Br J Haematol. 1999 Sep;106(3):682-8. doi: 10.1046/j.1365-2141.1999.01598.x. Br J Haematol. 1999. PMID: 10468856 Free article.

5

Splenectomy in myelofibrosis with myeloid metaplasia: a single-institution experience with 223 patients.

Tefferi A, Mesa RA, Nagorney DM, Schroeder G, Silverstein MN. Tefferi A, et al. Among authors: mesa ra. Blood. 2000 Apr 1;95(7):2226-33. Blood. 2000. PMID: 10733489 Free article.

6

Splenectomy in chronic myeloid leukemia and myelofibrosis with myeloid metaplasia.

Mesa RA, Elliott MA, Tefferi A. Mesa RA, et al. Blood Rev. 2000 Sep;14(3):121-9. doi: 10.1054/blre.2000.0132. Blood Rev. 2000. PMID: 10986148 Review.

7

Evaluation and clinical correlations of bone marrow angiogenesis in myelofibrosis with myeloid metaplasia.

Mesa RA, Hanson CA, Rajkumar SV, Schroeder G, Tefferi A. Mesa RA, et al. Blood. 2000 Nov 15;96(10):3374-80. Blood. 2000. PMID: 11071630 Free article.

8

Radiation therapy for symptomatic hepatomegaly in myelofibrosis with myeloid metaplasia.

Tefferi A, Jiménez T, Gray LA, Mesa RA, Chen MG. Tefferi A, et al. Among authors: mesa ra. Eur J Haematol. 2001 Jan;66(1):37-42. doi: 10.1034/j.1600-0609.2001.00342.x. Eur J Haematol. 2001. PMID: 11168506 Review.

9

Clinical and bone marrow effects of interferon alfa therapy in myelofibrosis with myeloid metaplasia.

Tefferi A, Elliot MA, Yoon SY, Li CY, Mesa RA, Call TG, Dispenzieri A. Tefferi A, et al. Among authors: mesa ra. Blood. 2001 Mar 15;97(6):1896. doi: 10.1182/blood.v97.6.1896. Blood. 2001. PMID: 11263440 Free article. Clinical Trial. No abstract available.

10

Clinical correlates of splenic histopathology and splenic karyotype in myelofibrosis with myeloid metaplasia.

Mesa RA, Li CY, Schroeder G, Tefferi A. Mesa RA, et al. Blood. 2001 Jun 1;97(11):3665-7. doi: 10.1182/blood.v97.11.3665. Blood. 2001. PMID: 11369668 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

307 results

Search Page

Filters